These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19855377)

  • 21. Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.
    Marotti JD; Collins LC; Hu R; Tamimi RM
    Mod Pathol; 2010 Feb; 23(2):197-204. PubMed ID: 19898422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR expression and activation are common in HER2 positive and triple-negative breast tumours.
    Koletsa T; Kotoula V; Karayannopoulou G; Nenopoulou E; Karkavelas G; Papadimitriou CS; Kostopoulos I
    Histol Histopathol; 2010 Sep; 25(9):1171-9. PubMed ID: 20607659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type.
    Monhollen L; Morrison C; Ademuyiwa FO; Chandrasekhar R; Khoury T
    Histopathology; 2012 Sep; 61(3):365-77. PubMed ID: 22486370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinicopathological study of triple-negative breast carcinoma in a patient cohort from a tertiary care center in Sri Lanka.
    Wijesinghe HD; Fernando J; Senarath U; Wijesinghe GK; S Lokuhetty MD
    Indian J Pathol Microbiol; 2020; 63(3):388-396. PubMed ID: 32769327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles.
    Gazinska P; Grigoriadis A; Brown JP; Millis RR; Mera A; Gillett CE; Holmberg LH; Tutt AN; Pinder SE
    Mod Pathol; 2013 Jul; 26(7):955-66. PubMed ID: 23392436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].
    Liu H; Fan QH; Zhang ZH; Li X; Yu HP; Liu GZ; Meng FQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients.
    Sable M; Pai TD; Shet T; Patil A; Dhanavade S; Desai SB
    Int J Surg Pathol; 2017 May; 25(3):230-237. PubMed ID: 27612858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis.
    Yu L; Yang W; Cai X; Shi D; Fan Y; Lu H
    Histopathology; 2010 Aug; 57(2):193-201. PubMed ID: 20716161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
    Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.
    Collins LC; Cole KS; Marotti JD; Hu R; Schnitt SJ; Tamimi RM
    Mod Pathol; 2011 Jul; 24(7):924-31. PubMed ID: 21552212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of basal-like subtype in triple-negative breast cancer.
    Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
    Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic profiling of lymph node negative breast cancers by means of microRNA expression.
    Janssen EA; Slewa A; Gudlaugsson E; Jonsdottir K; Skaland I; Søiland H; Baak JP
    Mod Pathol; 2010 Dec; 23(12):1567-76. PubMed ID: 20818337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.
    Bryan BB; Schnitt SJ; Collins LC
    Mod Pathol; 2006 May; 19(5):617-21. PubMed ID: 16528377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
    Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
    Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
    J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metaplastic breast carcinomas are basal-like tumours.
    Reis-Filho JS; Milanezi F; Steele D; Savage K; Simpson PT; Nesland JM; Pereira EM; Lakhani SR; Schmitt FC
    Histopathology; 2006 Jul; 49(1):10-21. PubMed ID: 16842242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.
    Sousa B; Paredes J; Milanezi F; Lopes N; Martins D; Dufloth R; Vieira D; Albergaria A; Veronese L; Carneiro V; Carvalho S; Costa JL; Zeferino L; Schmitt F
    Histol Histopathol; 2010 Aug; 25(8):963-74. PubMed ID: 20552547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
    Fadare O; Wang SA; Hileeto D
    Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer.
    Hussein YR; Sood AK; Bandyopadhyay S; Albashiti B; Semaan A; Nahleh Z; Roh J; Han HD; Lopez-Berestein G; Ali-Fehmi R
    Hum Pathol; 2012 Oct; 43(10):1638-44. PubMed ID: 22436627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
    Clark SE; Warwick J; Carpenter R; Bowen RL; Duffy SW; Jones JL
    Br J Cancer; 2011 Jan; 104(1):120-7. PubMed ID: 21139586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.